20 Recruiting Multiple Myeloma Interventional Protocol Clinical Trials
Active interventional protocol studies for multiple myeloma enrolling across the USA. Verify eligibility and contact site coordinators.
All Multiple Myeloma studiesInterventional Protocol Studies for Multiple Myeloma
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Telehealth-based Symptom Management for Veterans Treated With Selinexor
📍 Durham VA Medical Center — Durham, North Carolina
View Study & Checklist ➔Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
📍 Local Institution — Birmingham, Alabama
View Study & Checklist ➔Biomarker for Infection Risk in CLL and MM
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Multiple Myeloma Molecular Monitoring Study
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
📍 Hartford Healthcare Alliance — Hartford, Connecticut
View Study & Checklist ➔Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Registry for Adults With Plasma Cell Disorders (PCD's)
📍 North Carolina Cancer Hospital — Chapel Hill, North Carolina
View Study & Checklist ➔A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
📍 CTCA at Western Regional Medical Center — Goodyear, Arizona
View Study & Checklist ➔Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
📍 Center for International Blood and Marrow Transplant Research — Minneapolis, Minnesota
View Study & Checklist ➔Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
📍 University of Miami Hospitals — Miami, Florida
View Study & Checklist ➔Delayed Toxicities Post-CAR-T
📍 UCSF Medical Center — San Francisco, California
View Study & Checklist ➔Sleep Apnea in Patients With MGUS and MM
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
📍 Kirklin Clinic of UAB Hospital — Birmingham, Alabama
View Study & Checklist ➔Collection of Samples and Clinical Data From Patients With Amyloid Diseases
📍 Boston University Cancer Research Center — Boston, Massachusetts
View Study & Checklist ➔Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
📍 All4Cure — Seattle, Washington
View Study & Checklist ➔CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
📍 Atrium Health Levine Cancer — Charlotte, North Carolina
View Study & Checklist ➔Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
📍 Jewish General Hospital — Montreal, Quebec
View Study & Checklist ➔